title: Increased intracellular cyclic AMP levels suppress the mitogenic responses of human astrocytoma cells to growth factors.
abstract: It has been shown that the intracellular cAMP levels were decreased in human malignant astrocytomas. On the other hand, various growth factors and their receptors were found to be overexpressed in these tumors. It is therefore intriguing as to whether there is interplay between the two phenomena in the modulation of the astrocytoma cell growth. In a basal medium consisting of 75% DMEM, 25% Ham's F-12 supplemented with 2% FBS, we show that the mitogenic effects of platelet-derived growth factor (PDGF), basic fibroblast growth factor (bFGF), and epidermal growth factor (EGF) on human astrocytoma cells were suppressed by dibutyryl-cAMP. Dibutyryl-cAMP alone neither potentiated nor inhibited the tumor cell growth. Further studies show that PDGF-induced receptor autophosphorylation in human astrocytoma cells is suppressed by increased intracellular cAMP levels as measured by immunoprecipitation with anti-PDGF receptor and antiphosphotyrosine antibodies. Our results indicate that there is antagonistic interplay between the receptor tyrosine kinase pathway and cAMP-dependent protein kinase pathway in the control of the malignantly transformed glial cells. A reduced cAMP level seen in many human astrocytoma cells may favor their response to growth factor mitogenesis.
authors.affiliation: Department of Neurology, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
authors.forename: C H
authors.initials: CH
authors.lastname: Tsai
authors.forename: L M
authors.initials: LM
authors.lastname: Hung
authors.forename: H P
authors.initials: HP
authors.lastname: Cheng
authors.forename: J K
authors.initials: JK
authors.lastname: Chen
mesh_terms: D001254:Astrocytoma / Q000378:metabolism / Q000473:pathology*; D015153:Blotting, Western; D001932:Brain Neoplasms / Q000378:metabolism / Q000473:pathology*; D003994:Bucladesine / Q000494:pharmacology*; D002455:Cell Division / Q000187:drug effects; D000242:Cyclic AMP / Q000378:metabolism; D005904:Glial Fibrillary Acidic Protein / Q000378:metabolism; D006133:Growth Substances / Q000494:pharmacology*; D006801:Humans; D007150:Immunohistochemistry; D008934:Mitogens / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D010766:Phosphorylation; D020794:Receptor Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D013936:Thymidine / Q000378:metabolism; D014407:Tumor Cells, Cultured; D014443:Tyrosine / Q000378:metabolism
chemical_list: D005904:Glial Fibrillary Acidic Protein; D006133:Growth Substances; D008934:Mitogens; D014443:Tyrosine; D003994:Bucladesine; D000242:Cyclic AMP; D020794:Receptor Protein-Tyrosine Kinases; D013936:Thymidine